Pacific Biosciences of California, Inc. (PACB)
1.66
+0.08
(+5.06%)
USD |
NASDAQ |
Feb 24, 16:00
1.68
+0.02
(+1.20%)
Pre-Market: 08:07
Pacific Biosciences of California Profit Margin (Quarterly) : -90.43% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | -1.16K% |
| Twist Bioscience Corp. | -29.42% |
| Boston Scientific Corp. | 12.68% |
| Intellia Therapeutics, Inc. | -735.2% |
| Enovis Corp. | -104.0% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -389.6% |
| Return on Assets | -60.25% |
| Return on Invested Capital | -65.41% |
| Gross Profit Margin (Quarterly) | 37.52% |
| Operating Margin (Quarterly) | -92.28% |
| Return on Net Operating Assets | -98.11% |